We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

138 hedge funds and large institutions have $552M invested in Cardiovascular Systems, Inc. in 2016 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 12

123% more call options, than puts

Call options by funds: $958K | Put options by funds: $430K

33% more funds holding

Funds holding: 104138 (+34)

32% more capital invested

Capital invested by funds: $417M → $552M (+$135M)

12% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
138
Holders Change
+34
Holders Change %
+32.69%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
46
Increased
38
Reduced
34
Closed
12
Calls
$958K
Puts
$430K
Net Calls
+$528K
Net Calls Change
+$285K
Name Holding Trade Value Shares
Change
Change in
Stake
DTL
101
Dynamic Technology Lab
Singapore
$271K +$251K +11,453 New
UBS AM
102
UBS AM
Illinois
$247K -$1.22M -55,561 -84%
PIM
103
Partner Investment Management
California
$245K +$226K +10,307 New
CSS
104
Cubist Systematic Strategies
Connecticut
$227K +$209K +9,543 New
EP
105
Elkhorn Partners
Nebraska
$221K -$81K -3,700 -28%
BCM
106
Bayesian Capital Management
New York
$220K +$203K +9,284 New
SWP
107
Stratos Wealth Partners
Ohio
$215K +$198K +9,050 New
T. Rowe Price Associates
108
T. Rowe Price Associates
Maryland
$209K -$63.5K -2,900 -25%
US Bancorp
109
US Bancorp
Minnesota
$181K
Barclays
110
Barclays
United Kingdom
$175K -$176K -8,055 -52%
CG
111
Cutler Group
California
$154K -$27.7K -1,265 -16%
BNP Paribas Financial Markets
112
BNP Paribas Financial Markets
France
$129K +$33.7K +1,540 +39%
Legal & General Group
113
Legal & General Group
United Kingdom
$90K -$19.7K -899 -19%
WA
114
WFG Advisors
Texas
$76K -$442K -20,175 -86%
Canada Life
115
Canada Life
Manitoba, Canada
$76K
BlackRock
116
BlackRock
New York
$71K -$6.09K -278 -9%
Citigroup
117
Citigroup
New York
$67K -$2.04K -93 -3%
Bank of America
118
Bank of America
North Carolina
$63K -$36.9K -1,685 -39%
Fifth Third Bancorp
119
Fifth Third Bancorp
Ohio
$59K
Walleye Trading
120
Walleye Trading
New York
$47K +$43.8K +2,000 New
BJ
121
BlackRock Japan
Japan
$32K +$29.6K +1,354 New
Creative Planning
122
Creative Planning
Kansas
$24K
JP Morgan Chase
123
JP Morgan Chase
New York
$24K
KT
124
Kanaly Trust
Texas
$24K
AIM
125
Acrospire Investment Management
Illinois
$24K +$22K +1,006 New

CSII Hedge Fund Activity: Q3 2016 in Review

138 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2016, worth a combined $552M — up 32% from $417M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CSII positions and 12 closed out — a net gain of 34 holders — while 38 added to existing stakes and 34 trimmed.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $11M. The largest seller was Camber Capital Management, cutting an estimated $24.1M.

  • 138 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2016, up from 104 in Q2 2016.
  • Funds reported $552M of Cardiovascular Systems, Inc. stock for Q3 2016, up 32% quarter-over-quarter.
  • 46 funds opened new Cardiovascular Systems, Inc. positions in Q3 2016 and 12 closed out, a net change of +34 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2016 was PFM Health Sciences, an estimated $11M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2016 was Camber Capital Management, an estimated $24.1M sold.

Based on aggregated 13F filings for Q3 2016.